Evidence map›Paper›PMID 22761553›Full record

ArticlePLoS computational biology2012

Viral perturbations of host networks reflect disease etiology.

Natali Gulbahce, Han Yan, Amélie Dricot, Megha Padi, Danielle Byrdsong, Rachel Franchi, Deok-Sun Lee, Orit Rozenblatt-Rosen, Jessica C Mar, Michael A Calderwood and 22 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Network medicine framework for identifying drug-repurposing opportunities for COVID-19.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Frontiers in pharmacology · 2021
    Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 4 institutions in 2 countries.

Natali GulbahceCenter for Complex Networks Research-CCNR and Department of Physics, Northeastern University, Boston, Massachusetts, United States of America.
Han Yan
Amélie Dricot
Megha Padi
Danielle Byrdsong
Rachel Franchi
Deok-Sun Lee
Orit Rozenblatt-Rosen
Jessica C Mar
Michael A Calderwood
Amy Baldwin
Bo Zhao
Balaji Santhanam
Pascal Braun
Nicolas Simonis
Kyung-Won Huh
Karin Hellner
Miranda Grace
Alyce Chen
Renee Rubio
Jarrod A Marto
Nicholas A Christakis
Elliott Kieff
Frederick P Roth
Jennifer Roecklein-Canfield
James A Decaprio
Michael E Cusick
John Quackenbush
David E Hill
Karl Münger
Marc Vidal
Albert-László Barabási
Harvard University · USDana-Farber Cancer Institute · USBrigham and Women's Hospital · USNortheastern University · US

Funding

Genomic Analysis of Network Perturbations in Human DiseaseP50HG004233 · NHGRI · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2007 to 2017
$31.6M
The C. elegans Interactome ProjectR01HG001715 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HILL, DAVID E., ROTH, FREDERICK P · 1998 to 2010
$16.5M
Rewiring Pathways and Networks by Environmental PerturbationsR01ES015728 · NIEHS · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2007 to 2010
$2.2M
How Genetic Variation in Protein Kinases Affects Drug ResponseR21MH087394 · NIMH · HARVARD MEDICAL SCHOOL · PI HARLOW, EDWARD E · 2009 to 2010
$1.3M
NHGRI NIH HHS P50 HG004233NHGRI NIH HHS P50-HG004233NHGRI NIH HHS R01 HG001715NHGRI NIH HHS R01-HG001715NIEHS NIH HHS R01 ES015728NIEHS NIH HHS R01-ES015728NIMH NIH HHS MH087394NIMH NIH HHS R21 MH087394
6 · The paper itself

Abstract

Many human diseases, arising from mutations of disease susceptibility genes (genetic diseases), are also associated with viral infections (virally implicated diseases), either in a directly causal manner or by indirect associations. Here we examine whether viral perturbations of host interactome may underlie such virally implicated disease relationships. Using as models two different human viruses, Epstein-Barr virus (EBV) and human papillomavirus (HPV), we find that host targets of viral proteins reside in network proximity to products of disease susceptibility genes. Expression changes in virally implicated disease tissues and comorbidity patterns cluster significantly in the network vicinity of viral targets. The topological proximity found between cellular targets of viral proteins and disease genes was exploited to uncover a novel pathway linking HPV to Fanconi anemia.

Indexed as

Models, BiologicalComputational BiologyDiseaseFanconi AnemiaGenetic Predisposition to DiseaseHerpesvirus 4, HumanHost-Pathogen InteractionsHuman papillomavirus 16HumansProtein Interaction MapsViral ProteinsVirus DiseasesViral Proteins

Identifiers

PMID22761553
PMCPMC3386155
OpenAlexW2169382766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.